The winter cold season is at its peak, but the penny stock of UV Flu Technologies, Inc. (UVFT) is just getting warmed up. Ending last week on a high note, a flurry of interested traders were not willing to let a sniffle of a decimal point pass them by as they accumulated as much UVFT stock as they could. On the heels of their collaboration with Vystar’s Vytex® Natural Rubber Latex to help create “The Perfect Sleep Environment” by adding their UV-based, microbe-, spore- and germ-killing air purification system to it, sleeping too long past the daylight savings time change today could cost you a pretty penny.
Our Next Pick Is Coming Soon!
Click HERE To Make Sure You Don’t Miss Any Of Our Hot Penny Stock Alerts!
UVFT Stock Quote
Market Cap: 4.49M
Last: 0.0648 ▲ +0.0248 (+62.00%)
Dollar Volume: $135,463
Issued and Outstanding: 69,304,263
14-Day Rel Strength: 80.18%
1st Resistance Point: 0.0732
1st Support Level: 0.0482
Looking for the Best Penny Stocks to Buy?
Click HERE To Receive FREE Penny Stock Alerts
UV Flu Technologies has been focused on making your home a “cleaner environment” for quite some time now as evidenced by the FDA warning issued back on March 23, 2010. Call it aggressive marketing for their Viraguard UV 400 Air Purifier if you will, the warning was simply due to non-approval by the FDA for the products use in the diagnosis, mitigation, prevention, treatment, or cure of the 2009 H1N1 Flu Virus.
Be that as it may, UV Flu Technologies is fresh off their 10-K filing for the year ended December 31, 2013. Although it’s a bit of a concern that officer and directors own just over 1,000,000 shares of UVFT, it’s noteworthy to see that they have made strides in the commercial market for air purification products which is estimated to be worth over $5 billion.
The 10-K states how UV Flu Tech’s products are numerous hair and nail salons, restaurants, casinos, military installations, pet kennels, test labs, and over 600 hospitals worldwide, including the Baylor Healthcare System, Kaiser Permanente, the George Washington University Hospital, Providence Medical Center, and the University Medical Center.
Revenues for the year ended December 31, 2013 topped out at $213,797 versus $155,871 for the same 12 month period in 2012. In stride with the revenue growth, G&A expenses also grew to $1,007,044 versus $847,727 for the same 12 month period in 2012, making it all but impossible for the development stage company to reach break even.
The encouraging factor for that growth potential to be met is that current liabilities for UV Flu Tech, as of December 31, 2013, were only $174,234. Issue and outstanding shares are also nearly maxed out which means that dilution should not be a factor moving ahead for those looking to long UVFT stock.
While a “The Perfect Sleep Environment” is something only those who really value a good night sleep or suffer from certain respiratory problems would be willing to shell out some cash to buy, the Asian marketplace is head over heels for this kind of product. If they do bust out some reports of inking multi-million dollar contracts with potential partners, manufacturers, suppliers and distributors that they hooked up with at CES, UVFT stock could catch fire.
About UVFT Stock
UV Flu Technologies, Inc. is a development stage company focused on the research, development, manufacturing, and sales of air purification systems and products.
Last 5 Trading Sessions:
UVFT stock is one of the few penny stocks in the air purification business that actually has made positive strides over the past couple of years. With the recent interest in UVFT having heated up to a level not seen in nearly 2 years, is it silly to think 0.30 could be touched again this month?
Our Next Pick Is Coming Soon!
Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!